Humulin ® (human insulin)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Humulin Summary of Product Characteristics (SmPC)

Humulin® S, Humulin® I, Humulin® M3 100 Units/ml (insulin human): Posology and method of administration

The dosage should be determined by the physician, according to the requirement of the patient.

Posology

The dosage should be determined by the physician, according to the requirement of the patient.

Paediatric population

No data are available

Method of administration

Humulin S (Soluble insulin)

Humulin S in cartridges is only suitable for subcutaneous injections from a reusable pen. If administration by syringe or intravenous injection is necessary, a vial should be used.

Humulin S in vials should be given by subcutaneous injection but may, although not recommended, also be given by intramuscular injection. It may also be administered intravenously.

Humulin I (Isophane insulin) and Humlin M3 (30% soluble/70% isophane insulin)

Humulin I and Humulin M3 in vials should be given by subcutaneous injection but may, although not recommended, also be given by intramuscular injection. These formulations should not be administered intravenously.

Humulin I and Humulin M3 in cartridges is only suitable for subcutaneous injections from a reusable pen. These formulations should not be administered intravenously.

Humulin I and Humulin M3 in pre-filled pen is only suitable for subcutaneous injections. These formulations should not be administered intravenously.

Humulin I

Humulin I may be administered in combination with Humulin S. (See Instructions for use and handling for Mixing of Insulins).

Humulin M3

Humulin Mixture formulation is a ready-made defined mixture of soluble and isophane insulin designed to avoid the need for the patient to mix insulin preparations. A patient's treatment regimen should be based on their individual metabolic requirements.

Subcutaneous administration should be in the upper arms, thighs, buttocks or abdomen. Use of injection sites should be rotated so that the same site is not used more than approximately once a month.

Care should be taken when injecting any Humulin insulin preparations to ensure that a blood vessel has not been entered. After any insulin injection, the injection site should not be massaged. Patients must be educated to use proper injection techniques.

Each pack contains a patient information leaflet with instructions on how to inject insulin.

Reference

Humulin S 100 cartridge Summary of Product Characteristics

Humulin S 100 vial Summary of Product Characteristics Characteristics

Humulin I 100 cartridge Summary of Product Characteristics

Humulin I 100 SPC KwikPen Summary of Product Characteristics

Humulin I 100 SPC vial Summary of Product Characteristics

Humulin M3 100 cartridge Summary of Product Characteristics

Humulin M3 100 KwikPen Summary of Product Characteristics

Humulin M3 100 vial Summary of Product Characteristics

Date of Last Review: May 30, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question